US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
65

6523.T

Stock PHC Holdings Corporation
$1224.00

Tokyo Stock Exchange · Healthcare · JP

Sharia status
NOT COMPLIANT
Per In-house ratio engine · assessed 2026-08-26
HTR non-permissible income 0.09%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

PHC Holdings Corporation (6523.T) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-26). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Price target
$1414.29
+15.5% · 7 analysts
Institutional own.
8.4%
of shares
NON-COMPLIANT
Sharia compliance
0.09%
Non-permissible income — HTR, from filings (2026-03-31)
$1414.29
Price target (+15.5%) · 7 analysts
8.4%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2026-03-31. 6523.T files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail

RatioValueThresholdResult
Interest-bearing debt 121.38% 30.00% Fail
Interest-bearing investments 23.15% 30.00% Pass
Non-permissible income 0.09% 5.00% Pass

Usmani Fail

RatioValueThresholdResult
Interest-bearing debt 43.24% 33.00% Fail
Interest-bearing investments 8.25% 33.00% Pass
Non-liquid assets 78.80% at least 20.00% Pass
Non-permissible income 0.09% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 43.24% 33.33% Fail
Cash + interest-bearing securities 8.25% 33.33% Pass
Accounts receivable 21.20% 33.33% Pass
Non-permissible income 0.09% 5.00% Pass

FTSE Fail

RatioValueThresholdResult
Interest-bearing debt 43.24% 33.33% Fail
Cash + interest-bearing securities 8.25% 33.33% Pass
Accounts receivable 21.20% 50.00% Pass
Non-permissible income 0.09% 5.00% Pass

Dow Jones Islamic Market Fail

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 147.29% 33.00% Fail
Cash + interest-bearing securities 28.10% 33.00% Pass
Accounts receivable 44.14% 33.00% Fail
Non-permissible income 0.09% 5.00% Pass

S&P Shariah Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 138.85% 33.00% Fail
Cash + interest-bearing securities 26.49% 49.00% Pass
Accounts receivable 41.60% 49.00% Pass
Non-permissible income 0.09% 5.00% Pass

MSCI M-Series Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 138.85% 33.33% Fail
Cash + interest-bearing securities 26.49% 33.33% Pass
Accounts receivable 68.09% 49.00% Fail
Non-permissible income 0.09% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

1,598.001,430.871,263.731,096.60929.462025-09-122026-03-172026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
1208.33
S2
1220.67
S1
1235.33
PIVOT
1247.67
R1
1262.33
R2
1274.67
R3
1289.33

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
1,289.54 1,582.46
±10.2% from 1,436.00, made 2026-09-05 · resolves 2026-09-12
BUY
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22604 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
4 buy · 0 neutral · 8 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)35.30NEUTRAL
Stochastic %K (14)6.05BUY
CCI (20)-176.95BUY
Williams %R (14)-93.95BUY
MACD (12,26,9)-47.80SELL
ROC (10)-20.52SELL
Momentum (10)-316.00SELL
EMA (10)1349.36SELL
SMA (10)1399.70SELL
EMA (20)1370.26SELL
SMA (20)1439.70SELL
EMA (30)1346.12SELL
SMA (30)1367.33SELL
EMA (50)1288.75SELL
SMA (50)1251.00SELL
EMA (100)1200.60BUY
SMA (100)1144.20BUY
EMA (200)1130.38BUY
SMA (200)1103.21BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About PHC Holdings Corporation

Healthcare · Medical Devices

PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management, Healthcare Solutions, and Diagnostics & Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer and cell expansion bioreactor system; and diagnostic testing comprising clinical testing, diagnostic reagents, and digital diabetes management solutions. The company also provides patient record and billing solutions, which include electronic medical record systems and receipt systems, systems for pharmacies, and wellness and prevention; diabetes management technology, such as blood and continuous glucose monitoring systems; and medical device and drug delivery comprising contract development and manufacturing services, drug delivery systems, and digital health. It serves patients, healthcare professionals, and researchers. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was founded in 1948 and is headquartered in Chiyoda, Japan.

phchd.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

🕌 In-house Ratio Research — EDINET XBRL (Japan)

Research only, not the primary verdict above — SEC EDGAR (the source for the main in-house research card, if shown) has no data for this symbol, so this is computed from a real, country-specific filing instead. Business-activity screening isn't part of this check.

AAOIFI Standard 21 (% of market cap) — Fail
Debt ratio 151.5% (< 30%)
Investments ratio partial 25.7% (< 30%)
Non permissible income ratio no data
Usmani (% of total assets) — Fail
Debt ratio 43.2% (< 33%)
Investments ratio partial 7.3% (< 33%)
Non permissible income ratio no data

Based on the filing period ending 2026-03-31, figures in JPY.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.